The current price of FHTX is $1.91 — it has decreased by 9.29% since the previous close. Data as of Nov 5, 2026.
FHTX is down 8.41% over the past week, down 4.75% over the past month and down 52.38% over the past year. The price is below its 200-day moving average of $4.65.
Analysts' average 12-month price target for FHTX is $4.00, which implies 109.97% upside from the current price. Individual estimates range from $2.00 to $5.00.
Of the 10 analysts covering Foghorn Therapeutics Inc., 5 rate it a buy and 5 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Foghorn Therapeutics Inc. has a market capitalization of $113.13M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Foghorn Therapeutics Inc. posted a loss of $0.10 per share against an estimate of -$0.245, beating expectations by 59.18%. Upcoming reports are listed in the earnings calendar.
Foghorn Therapeutics Inc. reported revenue of $16.1M in its most recent quarter, which has increased by 113.05% compared with the same quarter a year earlier. Analysts had expected $6.81M.
Foghorn Therapeutics Inc. has not paid any dividends over the past year.
Companies most comparable to Foghorn Therapeutics Inc. include Assembly Biosciences, Inc., Zura Bio Limited, Enanta Pharmaceuticals, Inc., Sagimet Biosciences Inc. and Arcturus Therapeutics Holdings Inc.
In the latest trading session FHTX moved between $1.80 and $2.10, a range of 15.75% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Foghorn Therapeutics Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Foghorn Therapeutics Inc. is strong sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks FHTX has traded between $1.79 and $7.61. The current price is 74.97% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.